Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer

Objective: To explore the genetic changes in the progression of castration-resistant prostate cancer (CRPC) and neuroendocrine prostate cancer (NEPC) and the reason why these cancers resist existing therapies. Methods: We employed our CRPC cell line microarray and other CRPC or NEPC datasets to scre...

全面介紹

書目詳細資料

發表在:	Cancer Biology & Medicine
Main Authors:	Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li, Hai Huang
格式:	Article
語言:	英语
出版:	China Anti-Cancer Association 2022-08-01
主題:	crpc neil3 nepc prostate cancer radiotherapy resistance
在線閱讀:	https://www.cancerbiomed.org/content/19/8/1193